14 Best Low Risk High Growth Stocks to Buy Right Now
The US economy is navigating a period of heightened volatility, defined by a sharp geopolitical tax on consumers and a resilient but stressed financial sector.
Novartis A G (NVS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 13,885,749 | $2,121,048,400 | +86% | 0.72% |
| 2. | Arjuna Capital Farnum Brown And Adam Seitchik | 27,009 | $4,125,625 | +10% | 1.05% |
| 3. | Diamond Hill Capital Ric Dillon | 24,822 | $3,791,561 | 0.02% | |
| 4. | Kahn Brothers Irving Kahn | 13,386 | $2,044,711 | -3% | 0.36% |
| 5. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,110,116 | $1,238,669,129 | 0.26% | |
| 2. | 2,311,384 | $353,063,930 | 0.09% | |
| 3. | 1,793,153 | $273,904,121 | 0.04% | |
| 4. | 1,532,789 | $234,133,650 | 0.13% | |
| 5. | 1,463,180 | $220,003,745 | 0.5% |
News See All
Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study
Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in now.
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Novartis AG (NYSE:NVS) is one of the top gene therapy stocks to buy according to hedge funds.
Top 10 Gene Therapy Stocks to Buy According to Hedge Funds
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
Where is Novartis AG (NVS) Headed?
Novartis AG (NYSE:NVS) is one of the best immunotherapy stocks to buy according to hedge funds.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets and what may drive ...
Novartis AG (NYSE:NVS) Q4 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q4 Full Year 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded.
Why Analysts Are Closely Watching Novartis AG (NVS)
Novartis AG (NYSE:NVS) is among the most profitable healthcare stocks to buy.
10 Most Profitable Healthcare Stocks to Buy
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
Hedge Fund Resource Center